adjuvant chemotherapy) was not associated with recurrence rate, but this analysis is underpowered

adjuvant chemotherapy) was not associated with recurrence rate, but this analysis is underpowered. death-ligand 1 (PD-L1)) and markers of systemic inflammation could predict progression/relapse and death in the cohort of 180 patients with testicular germ-cell tumors (GCTs). Expression of PD-L1 and VISTA was assessed by immunohistochemistry utilizing tissue microarrays. To estimate systemic inflammation neutrophil-to-lymphocyte ratio… Continue reading adjuvant chemotherapy) was not associated with recurrence rate, but this analysis is underpowered